APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,222,440 | +1.9% | 111,000 | +144.0% | 0.67% | +16.0% |
| Q2 2023 | $4,144,595 | -26.5% | 45,495 | -46.8% | 0.58% | -26.9% |
| Q1 2023 | $5,640,240 | +95.8% | 85,510 | +53.5% | 0.79% | +100.3% |
| Q4 2022 | $2,879,988 | -78.6% | 55,695 | -71.8% | 0.39% | -78.2% |
| Q3 2022 | $13,475,000 | +130.1% | 197,290 | +52.3% | 1.80% | +126.7% |
| Q2 2022 | $5,856,000 | +130.3% | 129,508 | +158.8% | 0.80% | +178.0% |
| Q1 2022 | $2,543,000 | -48.0% | 50,040 | -51.6% | 0.29% | -59.6% |
| Q4 2021 | $4,890,000 | -35.2% | 103,425 | -13.4% | 0.71% | -24.3% |
| Q2 2021 | $7,549,000 | -2.2% | 119,445 | -11.5% | 0.94% | -12.5% |
| Q4 2020 | $7,719,000 | +917.0% | 134,945 | +376.0% | 1.07% | +325.5% |
| Q1 2020 | $759,000 | – | 28,350 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |